The way therapeutic opportunities are often evaluated today is through a heavy dose of consultants, hundreds of slides, and ultimately highly fragmented and incomplete information. We believe this high content, low insight process is a core driver of inefficiency in the industry. Maven is building the platform that will allow stakeholders of all disciplines to effectively evaluate therapeutic opportunities.

To start, Maven is building a biopharma commercial intelligence platform which allows corporate development teams to rapidly construct deal landscapes and conduct comparative analyses. Maven empowers users with evidence-backed insights based on their business context. Over time, Maven will add additional knowledge areas to the platform to provide an increasingly comprehensive and accurate assessment of a therapeutic opportunity.

We are a professional team that takes ownership and initiative. In particular we want to work people who love learning, and are excited by the opportunity to take full ownership of defining, designing, and building features.